Advertisement

Allergan cutting 1,000 jobs in cost-cutting move

January 03, 2018 11:54 AM

NEW YORK (AP) — Allergan will eliminate about 5.5 percent of its workforce as part of a cost-cutting move while it prepares for generic competition on several lucrative drugs.

Advertisement

The company will cut 1,000 jobs and leave another 400 open positions unfilled. The Dublin-based company has about 18,000 employees.

Allergan expects restructuring costs of about $125 million and savings of $300 million to $400 million.

The company will likely face generic competition for its dry-eye drug Restasis, which helped boost revenue for eye care products by 4.4 percent to $635.5 million during the third quarter. A federal judge ruled against Allergan in a patent dispute in 2017 and the company reported a $3.2 billion charge following the loss.

Allergan is also expected to face generic competition for its Alzheimer's drug Namenda.

Credits

Copyright 2018 The Associated Press. All rights reserved.

Advertisement



Advertisement

Relay Media Amp

Advertisement


Advertisement




Governor optimistic on economy, crime plan; Democrats' agenda differs

Budget battle expected in Roundhouse this session

Martinez hopes 2018 'will be a win for New Mexicans'

Drug abuse, property crime are concerns in rural districts

APD: Man killed in police shooting was armed, charged at officers